Wordt geladen...
Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET
Background: Rationalization of antiangiogenics requires biomarkers. Vascular re‐normalization is one widely accepted mechanism of action for this drug class. The interstitium of tumors with abnormal vasculature is hypoxic. We sought to track vascular normalization with 18F‐misonidazole ([18F]‐FMISO,...
Bewaard in:
| Gepubliceerd in: | Mol Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5423153/ https://ncbi.nlm.nih.gov/pubmed/26778791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.12.011 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|